Browsing by Autor "Oscar Rillo"

Now showing 1 - 6 of 6

A patients’ view of OA: the Global Osteoarthritis Patient Perception Survey (GOAPPS)
(2020) Marianna Vitaloni; Angie Botto‐van Bemden; Rosa Sciortino; Xavier Carné; Maritza Quintero; Pedro Santos-Moreno; R. Espinosa; Oscar Rillo; Jordi Monfort; Francisco J. de Abajo
<title>Abstract</title> <bold>Background:</bold> Globally, osteoarthritis (OA) is the third condition associated with disability. There is still poor treatment in OA but science holds the key to finding better treatments and a cure. It is essential to learn what’s important to patients from them to implement the most effective OA management. The OA Patients Task Force, conducted the Global OA Patient Perception Survey (GOAPPS)-the first global survey to compare the quality of life (QoL) & patient perceptions of care across countries. The goal was to collect data on OA patients' perception of OA to understand patients’ needs and expectations to improve OA management.<bold>Methods:</bold> Observational, cross-sectional study by online survey data collection from six countries, translated into three languages. The survey was comprised of 3 sections: patient demographics and clinical symptomology characteristics; relationship with physicians: perception of attention, treatment, and information provided; and OA impact on daily activity and QoL. The results of the survey were evaluated using the Limited Data Set. The survey results were analyzed using descriptive statistics to characterize the patients' answers using the IBM SPSS<sup>®</sup> software.<bold>Results.</bold> A total of 1512 surveys were completed in 6 countries. 84.2% of respondents reported pain/tenderness and 91.1% experienced limitations to physical activities. 42.3% of patients were not satisfied with their current OA treatment. 86% had comorbidities, especially hypertension, and obesity. 51.3% and 78% would like access to additional drug or additional non-drug/non-surgical treatments respectively. 48.2% of patients perceived their QoL to be affected by OA <bold>Conclusions:</bold> OA has a significant impact on patients’ daily activities and their desire to play an active role in managing this disease. Patients are seeking additional treatments, especially no pharmacological/no surgical treatments stressing the need for investing in clinical research, implementing OA preventive measures, and managing interventions to improve the healthcare value chain in OA.
A patients’ view of OA: the Global Osteoarthritis Patient Perception Survey (GOAPPS)
(Research Square (United States), 2020) Marianna Vitaloni; Angie Botto‐van Bemden; Rosa Sciortino; Xavier Carné; Maritza Quintero; P. Santos-Moreno; R. Espinosa; Oscar Rillo; Jordi Monfort; Francisco J. de Abajo
Abstract Background Globally, osteoarthritis (OA) is the third condition associated with disability. There is still poor treatment in OA but science holds the key to finding better treatments and a cure. It is essential to learn what’s important to patients from them to implement the most effective OA management. The OA Patients Task Force, conducted the Global OA Patient Perception Survey (GOAPPS)-the first global survey to compare the quality of life (QoL) & patient perceptions of care across countries. The goal was to collect data on OA patients' perception of OA to understand patients’ needs and expectations to improve OA management.Methods Observational, cross-sectional study by online survey data collection into three languages. Patient demographics, symptomology, OA impact on daily activity and QoL data were collected. The questionnaire comprised of 4 sections: clinical characteristics, relationship with physicians, perception of attention, treatment, information, and QoL.Results A total of 1512 surveys were filled in 7 countries. 84.2% of respondents reported pain/tenderness and 91.1% experienced limitations to physical activities. 42.3% of patients were not satisfied with their current OA treatment. 86% had comorbidities, especially hypertension, and obesity. 51.3% and 78% would like access to additional drug or additional non-drug/non-surgical treatments respectively. 51.7% considered their QoL satisfactory.Conclusions OA has a significant impact on patients’ daily activities and the desire to play an active role in managing their disease. Patients seek additional treatments stressing the need for investing in clinical research, implementing OA preventive measures and managing interventions to improve the healthcare value chain in OA.
A patients’ view of OA: the Global Osteoarthritis Patient Perception Survey (GOAPPS), a pilot study
(Research Square (United States), 2020) Marianna Vitaloni; Angie Botto‐van Bemden; Rosa Sciortino; Xavier Carné; Maritza Quintero; Pedro Santos-Moreno; R. Espinosa; Oscar Rillo; Jordi Monfort; Francisco J. de Abajo
Abstract Background: Globally, osteoarthritis (OA) is the third condition associated with disability. There is still poor treatment in OA but science holds the key to finding better treatments and a cure. It is essential to learn what’s important to patients from them to implement the most effective OA management. The OA Patients Task Force, conducted the Global OA Patient Perception Survey (GOAPPS)-the first global survey made by patients to analize the quality of life (QoL) & patient perceptions of care across countries. The goal was to collect data on OA patients' perception of OA to understand patients’ needs and expectations to improve OA management. Methods: Observational, cross-sectional study by online survey data collection from six countries, translated into three languages. The survey was comprised of 3 sections: patient demographics and clinical symptomology characteristics; relationship with physicians: perception of attention, treatment, and information provided; and OA impact on daily activity and QoL. The results of the survey were evaluated using the Limited Data Set. The survey results were analyzed using descriptive statistics to characterize the patients' answers. Additionally, Cronbach's alpha was calculated to determine internal consistency validity. Results. A total of 1512 surveys were completed in 6 countries. 84.2% of respondents reported pain/tenderness and 91.1% experienced limitations to physical activities. 42.3% of patients were not satisfied with their current OA treatment. 86% had comorbidities, especially hypertension, and obesity. 51.3% and 78% would like access to additional drug or additional non-drug/non-surgical treatments respectively. 48.2% of patients perceived their QoL to be affected by OA. The Cronbach's alpha was 0.61. Conclusions: OA has a significant impact on patients’ daily activities and their desire to play an active role in managing this disease. Patients are seeking additional treatments, especially no pharmacological/no surgical treatments stressing the need for investing in clinical research, implementing OA preventive measures, and managing interventions to improve the healthcare value chain in OA.
A patients’ view of OA: the Global Osteoarthritis Patient Perception Survey (GOAPPS), a pilot study
(Research Square (United States), 2020) Marianna Vitaloni; Angie Botto‐van Bemden; Rosa Sciortino; Xavier Carné; Maritza Quintero; Pedro Santos-Moreno; R. Espinosa; Oscar Rillo; Jordi Monfort; Francisco J. de Abajo
Abstract Background: Globally, osteoarthritis (OA) is the third condition associated with disability. There is still poor treatment in OA but science holds the key to finding better treatments and a cure. It is essential to learn what’s important to patients from them to implement the most effective OA management. The OA Patients Task Force, conducted the Global OA Patient Perception Survey (GOAPPS)-the first global survey made by patients to analize the quality of life (QoL) & patient perceptions of care across countries. The goal was to collect data on OA patients' perception of OA to understand patients’ needs and expectations to improve OA management. Methods: Observational, cross-sectional study by online survey data collection from six countries, translated into three languages. The survey was comprised of 3 sections: patient demographics and clinical symptomology characteristics; relationship with physicians: perception of attention, treatment, and information provided; and OA impact on daily activity and QoL. The results of the survey were evaluated using the Limited Data Set. The survey results were analyzed using descriptive statistics to characterize the patients' answers. Additionally, Cronbach's alpha was calculated to determine internal consistency validity. Results. A total of 1512 surveys were completed in 6 countries. 84.2% of respondents reported pain/tenderness and 91.1% experienced limitations to physical activities. 42.3% of patients were not satisfied with their current OA treatment. 86% had comorbidities, especially hypertension, and obesity. 51.3% and 78% would like access to additional drug or additional non-drug/non-surgical treatments respectively. 48.2% of patients perceived their QoL to be affected by OA. The Cronbach's alpha was 0.61. Conclusions: OA has a significant impact on patients’ daily activities and their desire to play an active role in managing this disease. Patients are seeking additional treatments, especially no pharmacological/no surgical treatments stressing the need for investing in clinical research, implementing OA preventive measures, and managing interventions to improve the healthcare value chain in OA.
Panlar consensus on hip osteoarthritis
(Elsevier BV, 2017) Oscar Rillo; R. Espinosa; Carlota Acosta; Maritza Quintero; Ligia Monterola; Edgar Nieto; L. Franco; R. Arapé; Sílvia Papasidero; Miguel Vera
PANLAR Consensus Recommendations for the Management in Osteoarthritis of Hand, Hip, and Knee
(Lippincott Williams & Wilkins, 2016) Oscar Rillo; Humberto Riera; Carlota Acosta; Verónica Liendo; Joyce Bolaños; Ligia Monterola; Edgar Nieto; R. Arapé; Luisa Franco; Mariflor Vera
These recommendations are based on the consensus of clinical experts from a wide range of disciplines taking available evidence into account while balancing the benefits and risks of nonpharmacological, pharmacological, and surgical treatment modalities, and incorporating their preferences and values. Different backgrounds in terms of patient education or drug availability in different countries were not evaluated but will be important.